Director or Officer Departures, Elections, Appointments, and Compensation Arrangements

SEC Filing Summary: Mainz Biomed N.V. (QUCY)

Business Context and Reporting Period

This Form 8-K was filed by Mainz Biomed N.V. on March 11, 2026. The registrant is incorporated in The Netherlands and operates as an emerging growth company. The filing reports on corporate governance changes and a ticker symbol change effective March 12, 2026.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.

Material Changes

  • Board Appointment: Robert P. Liscouski was appointed as a director and Chairman of the Board on March 11, 2026. His term expires at the extraordinary general meeting planned for April 2026.
  • Symbol Change: Effective March 12, 2026, the company's ordinary shares will cease trading under the ticker "MYNZ" and begin trading under the ticker "QUCY" on the Nasdaq Stock Market.
  • Security Rights: The symbol change does not affect the rights of security holders, and there is no change to the CUSIP.

Guidance, Outlook, and Risks

The filing does not contain financial guidance, management commentary on future performance, or specific risk factors beyond the standard disclosures regarding the symbol change. No unusual items or contingencies were reported in this document.

Investor Verification Checklist

  • Verify the new ticker symbol "QUCY" on the Nasdaq Stock Market starting March 12, 2026.
  • Confirm the background and qualifications of the newly appointed Chairman, Robert P. Liscouski.
  • Review the attached press release (Exhibit 99.1) for additional context on the leadership change.
  • Monitor the upcoming extraordinary general meeting in April 2026 for the ratification of the director's term.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.